Beam Therapeutics Inc.
United States of America (USA)
1 December 2019 - 30 November 2020
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Beam Therapeutics Inc. published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
3 | 2.30 |
Outputs by subject (Share)
Subject | Count | Share | |
---|---|---|---|
Life Sciences | 2 | 2 | |
Chemistry | 1 | 0.30 | |
Physical Sciences | 1 | 0.30 |
Top articles by Altmetric score in current window
Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing
Science Advances
2020-08-01
Directed evolution of adenine base editors with increased activity and therapeutic application
Nature Biotechnology
2020-04-13
Cytosine base editors with minimized unguided DNA and RNA off-target events and high on-target activity
Nature Communications
2020-04-28
1 December 2019 - 30 November 2020
International vs. domestic collaboration by Share
- 82.89% Domestic
- 17.11% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by Share (3 total)
- Beam Therapeutics Inc., United States of America (USA)
- Domestic institution
Top 10 international collaborators by Share (1 total)
- Beam Therapeutics Inc., United States of America (USA)
- Foreign institution
Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.